Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
Crossref DOI link: https://doi.org/10.1007/s00277-015-2468-y
Published Online: 2015-08-08
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Byeong-Bae
Kim, Won Seog
Suh, Cheolwon
Shin, Dong-Yeop
Kim, Jeong-A
Kim, Hoon-Gu
Lee, Won Sik
Text and Data Mining valid from 2015-08-08